Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis
Clinical trial NCT06376396 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06376396
- Sponsor
- R-Evolution Worldwide S.r.l. Impresa Sociale
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2025-12-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.